ValveDock TMVR

Transseptal Integrated System

WATCH VIDEO

ValveDock's MDock

Transseptal Docking Platform for Transcatheter Mitral Valves

ABOUT

ValveDock is a medical device startup company, based in The Netherlands, focussed on the emerging market of transcatheter mitral (TMVR) and tricuspid (TTVR) heart valve replacement.

ValveDock's patented integrated one-unit TMVR and TMVR Docking Platform enable the minimally invasive transseptal one-step and two-step deployment of transcatheter valved-stents, and may overcome most clinical problems observed with current generation TMVR and TTVR devices.

Our Team

The ValveDock's Team consists of highly experienced and ambitious executives from the valve manufacturing industry and medical specialists.

ValveDock Solutions

The proprietary unique design of ValveDock’s integrated one-piece TMVR and TMVR Docking Platform anchors all around and only at the level of the mitral valve origin (annulus), positioning the valved-stent between the left atrium and ventricle.

Mitral Valve Regurgitation

The mitral valve is one of the four valves in the human heart, located between the left atrium and left ventricle.